OBJECTIVE: To examine relationships of period of diagnosis of type 1 diabetes mellitus
(T1DM) to the prevalence of visual impairment (VI). DESIGN: Population-based longitudinal …

Purpose: DME is a vision threatening complication of diabetes. There are few national-level
data derived from large-scale studies that describe how ophthalmologists in the US manage …

Purpose To assess how patient choices (out-of-pocket costs, insurance plan, geographic
region) impact initiation of therapy for diabetic macular edema (DME). Design Retrospective …

Purpose This study characterizes the association of risk factors including race, ethnicity, and
insurance status with presenting visual acuity (VA) and diabetic retinopathy (DR) severity in …

Importance Diabetic macular edema (DME) is a leading cause of vision loss in persons with
diabetes mellitus. Although there are national estimates for the prevalence of diabetic …

Objective To examine trends in resource use and the effect of incident diabetic macular
edema (DME) on 1-and 3-year total direct medical costs in elderly patients. Methods We …

BACKGROUND AND OBJECTIVE: Diabetic macular edema (DME) is a leading cause of
blindness for non-elderly adults; however, health care-associated burden data from this …

ABSTRACT Aims/Introduction In older patients, the management of diabetic macular edema
(DME) can be complicated by comorbidities, geriatric syndrome, and socioeconomic status …

Diabetes mellitus (DM) is a rapidly growing epidemic in the United States, and it is expected
to affect 592 million individuals within the next 20 years. Diabetic retinopathy (DR) and …

Diabetic retinopathy is the leading cause of blindness in persons under age 60 in the United
States, and diabetic macular edema (DME) is the most common cause of visual loss in those …